Elite Pharmaceuticals, Inc. Common Stock (ELTP) Announces Earnings Results

Elite Pharmaceuticals, Inc. Common Stock (OTCMKTS:ELTP) issued its earnings results on Thursday. The specialty pharmaceutical company reported $0.00 EPS for the quarter, Zacks Earnings Dates reports. Elite Pharmaceuticals, Inc. Common Stock had a negative net margin of 55.87% and a negative return on equity of 38.74%.

Elite Pharmaceuticals, Inc. Common Stock traded up $0.00, reaching $0.09, during trading on Thursday, MarketBeat.com reports. 431,739 shares of the stock were exchanged, compared to its average volume of 731,408. The company has a quick ratio of 2.00, a current ratio of 3.11 and a debt-to-equity ratio of 0.56. Elite Pharmaceuticals, Inc. Common Stock has a 1 year low of $0.06 and a 1 year high of $0.21.

About Elite Pharmaceuticals, Inc. Common Stock

Elite Pharmaceuticals, Inc, a specialty pharmaceutical company, engages in the research, development, manufacture, and licensing of proprietary orally administered controlled-release drug delivery systems and products. The company operates in two segments, Abbreviated New Drug Applications for Generic Products and New Drug Applications for Branded Products.

Earnings History for Elite Pharmaceuticals, Inc. Common Stock (OTCMKTS:ELTP)

Receive News & Ratings for Elite Pharmaceuticals Inc. Common Stock Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elite Pharmaceuticals Inc. Common Stock and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply